Delivery Order SPE2DB20D7059-SPE2DB25FQCB3

Award Date 3/19/25
Potential Completion Date 3/20/25
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,329.45 firm fixed-price delivery order contract is for the supply of ANNOVERA vaginal rings, with a performance period extending through May 12, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,376.51 firm fixed-price delivery order is for the supply of ANNOVERA vaginal rings, with a performance period ending on April 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $20,810.57, is a Firm Fixed Price Delivery Order contract for the supply of ANNOVERA Vaginal Rings to support federal healthcare programs. The contract has an ultimate completion date of February 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,215.35 firm fixed-price delivery order covers the supply of ANNOVERA vaginal rings, with a period of performance through January 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,864.20 firm fixed-price delivery order is for the supply of ANNOVERA vaginal rings, with a period of performance through May 10, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ANNOVERA vaginal ring, a prescription medication, with a ceiling value of $30,126.33 and a period of performance through August 2, 2024. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at...
This federal contract award, valued at $4,506.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ANNOVERA vaginal rings, a prescription contraceptive product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. This award is not associated with a set-aside program and represents open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,073.30, is for the delivery of ANNOVERA vaginal rings and has an ultimate completion date of April 9, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,036.34 firm fixed-price delivery order is for the provision of ANNOVERA vaginal rings, a contraceptive product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,500.04 firm fixed-price contract is for the delivery of ANNOVERA vaginal rings, with a period of performance through April 11, 2025. This order is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQCB3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,121.48 firm fixed-price delivery order is for the supply of ANNOVERA vaginal rings, with a period of performance through March 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. There is no set-aside designation for this specific award.

Generated 6/18/25, 11:12 AM